Rudolphina Insights

Parkinson's research: message from the cell

29. July 2025
Many diseases result from faulty "waste disposal" within cells. Researchers at the University of Vienna have discovered a previously unknown trigger for this molecular recycling system. In the video series "Insights", group leader Sascha Martens explains the discovery that opens up new perspectives for therapies against Parkinson's disease.
Sascha Martens' research group at the Max Perutz Labs of the University of Vienna has discovered a previously unknown mechanism by which cells activate autophagy. Martens explains the discovery in this video. © University of Vienna / Corporate Communications

Autophagy can be thought of as the "waste disposal system" by which cells cleanse themselves. An elaborate molecular surveillance system identifies broken cell components, clumped proteins or even pathogens and initiates their removal. This prevents cellular "trash" from accumulating. 

Even entire cell organelles can be removed as part of this process. Mitophagy is a form of autophagy in which defective or excess mitochondria are broken down.

You may also read
Healthy cells, fit brain
A 'waste collection' tidies up our cells. If something does not go according to plan, serious diseases such as Alzheimer's or Parkinson's may develop. Molecular biologist Sascha Martens and his team investigate the associated process – autophagy.

Who gives the "trash removal" command?

Disruptions to these processes can have serious consequences, including the development of neurodegenerative diseases. In particular, dysfunctions in mitophagy are associated with Parkinson's disease. To combat Parkinson's disease, it is therefore important to understand the exact molecular processes underlying mitophagy.

Led by postdoctoral researcher Elias Adriaenssens from Sascha Martens' group, researchers from the Max Perutz Labs at the University of Vienna have discovered a new mechanism that triggers mitophagy. 

So far, mitophagy research has been focusing primarily on the "PINK1/Parkin signalling pathway". Signalling pathways transmit information within cells. These complex networks of molecules control critical cellular functions such as growth, division, cell death and also mitophagy. 

"We realised that there were huge gaps in our knowledge beyond PINK1/Parkin," explains study leader Elias Adriaenssens. "Therefore, we decided to investigate signalling pathways which have been largely neglected by researchers. By trying to recreate the signalling pathways in the laboratory, we were able to gain fundamental insights into the mechanisms behind them."

New players in autophagy

To their surprise, the researchers discovered that two known mitophagy receptors can trigger autophagy without binding to the FIP200 protein. FIP200 was previously considered indispensable for triggering autophagy. "That presented us with a conundrum. We asked ourselves how the receptors work without this supposedly crucial protein," says Adriaenssens. 

The researchers found that "WIPI proteins" bind to the receptors. The fact that they are involved in triggering autophagy is a surprising discovery ‒ it was previously assumed that WIPI proteins act only later in the signalling pathway.

Die Forschungsgruppe im Porträt
Meet the scientists
Sascha Martens and his team are investigating the mysterious degradation pathways in our cells. In this video, the biochemists from the University of Vienna reveal what keeps them going – despite failures and being borne away: Team spirit, the passion for a topic and their common goal of making a difference.

Perspectives for Parkinson's research

Subsequent experiments confirmed that this interaction between the receptors and the WIPI proteins is not an exception but may indicate the presence of previously unknown signalling pathways. "This is an exciting discovery that reveals a parallel trigger for selective autophagy. Instead of a single, universal mechanism, cells appear to use different molecular strategies depending on the receptor and context," says Adriaenssens.

The study raises an important question: How do cells decide between alternative mitophagy signalling pathways? Understanding this could pave the way for treatments that specifically activate one signalling pathway to compensate for defects in the other, which has long-term potential for the treatment of Parkinson's disease.

 

© Daniel Hinterramskogler
© Daniel Hinterramskogler
Sascha Martens is Professor of Membrane Biochemistry at the Centre for Molecular Biology (Max Perutz Labs) since 2017. His research focuses on biochemistry, cell biology, membrane biology and autophagy.

He moved to Vienna in 2009 from the MRC Laboratory of Molecular Biology in Cambridge to study autophagic pathways in yeast model organisms and human cells at the Max Perutz Labs.